tyramine has been researched along with Hyperlipoproteinemia Type II in 1 studies
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
Excerpt | Relevance | Reference |
---|---|---|
"Lactoferrin was found to inhibit binding and degradation of chylomicron remnants by fibroblasts from subjects with familial hypercholesterolaemia by approximately 50%, implicating involvement of the alpha 2-macroglobulin receptor." | 1.30 | Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia. ( Harada-Shiba, M; Kawaguchi, A; Mamo, JC; Smith, D; Yamamoto, A; Yamamura, T; YU, KC, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
YU, KC | 1 |
Smith, D | 1 |
Yamamoto, A | 1 |
Kawaguchi, A | 1 |
Harada-Shiba, M | 1 |
Yamamura, T | 1 |
Mamo, JC | 1 |
1 other study available for tyramine and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
Topics: Adult; Animals; Carcinogens; Cells, Cultured; Chylomicrons; Cytochalasin D; Fibroblasts; Homozygote; | 1997 |